Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.

Journal: Journal of medical Internet research
PMID:

Abstract

BACKGROUND: Psoriasis is one of the most frequent inflammatory skin conditions and could be treated via tele-dermatology, provided that the current lack of reliable tools for objective severity assessments is overcome. Psoriasis Area and Severity Index (PASI) has a prominent level of subjectivity and is rarely used in real practice, although it is the most widely accepted metric for measuring psoriasis severity currently.

Authors

  • Kai Huang
  • Xian Wu
    Beijing University of Posts and Telecommunications, Beijing 100876, China.
  • Yixin Li
    Digestive System Department, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Chengzhi Lv
    Department of Dermatology, Dalian Dermatosis Hospital, Liaoning, China.
  • Yangtian Yan
    Tencent, Beijing, China.
  • Zhe Wu
    School of Automation, Central South University, Changsha, China.
  • Mi Zhang
    Department of Electrical and Computer Engineering, Michigan State University, East Lansing, Michigan 48824; email: mizhang@egr.msu.edu.
  • Weihong Huang
    "Mobile Health" Ministry of Education - China Mobile Joint Laboratory, Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Zixi Jiang
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, China.
  • Kun Hu
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Mingjia Li
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Juan Su
    Department of Dermatology, Xiangya Hospital Central South University, Changsha, China.
  • Wu Zhu
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Fangfang Li
    Department of Dermatology, Xiangya Hospital, Central South University; Hunan Key Laboratory of Skin Cancer and Psoriasis; Hunan Engineering Research Center of Skin Health and Disease, Changsha 410008, China.
  • Mingliang Chen
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Jing Chen
    Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Yongjian Li
    Department of Dermatology, Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, China.
  • Mei Zeng
    Department of Dermatology, Shaoyang Central Hospital, Shaoyang, Hunan, China.
  • Jianjian Zhu
    Department of Public Administration, Xi'an University of Finance and Economics, Xi'an, Shaanxi 710016, China.
  • Duling Cao
    Department of Dermatology, Xiangtan Central Hospital, Xiangtan, Hunan, China.
  • Xing Huang
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Lei Huang
    School of Computer Science and Engineering, University of Electronic Science and Technology of China, Chengdu, China.
  • Xing Hu
    State Key Laboratory of Coal Combustion, Huazhong University of Science and Technology, 430074 Wuhan, Hubei, China.
  • Zeyu Chen
    Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA. zeyuchen@csu.edu.cn.
  • Jian Kang
    Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China.
  • Lei Yuan
    Department of Pharmacy, Baodi People's Hospital, Tianjin, China.
  • Chengji Huang
    China Mobile (Chengdu) Industrial Research Institute, Chengdu, Sichuan, China.
  • Rui Guo
    College of Chemistry&Chemical Engineering, Xiamen University, Xiamen 361005, China.
  • Alexander Navarini
    Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
  • Yehong Kuang
    Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Xiang Chen
    Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of China, Huzhou, Zhejiang, China.
  • Shuang Zhao
    Department of Microelectronics, Nankai University, Tianjin, 300350, PR China.